Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...

This week the University of Liverpool launched the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), an ...

L V Prasad Eye Institute highlights eye cancer is rare but serious threat that needs more awareness. Most people associate cancer with the lungs, breast, or skin, but few realize that cancer can also ...

Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of ...

A recent study published in the Nature Scientific Reports demonstrated that topical cyclosporin 0.1% is highly effective in ...

To take cues from central banks’ meetings (including the US Fed), further developments related to the global trade war, and ...

Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). Batoclimab, ...

Cardiff Oncology's Onvansertib shows promise in treating ... investors interested in Cardiff should keep an eye on the competition. As commented in previous sections, I consider Revolution ...

VIR's T-cell engagers have potential in oncology and showed promise with initial data in January 2025. Read my thoughts about VIR's near-term catalysts.

The oncology business, meanwhile ... not to proceed with a clinical trial of its RNAi drug vutrisiran in the rare eye disorder Stargardt disease, as the legislation exempts orphan drugs for ...

With demand for advanced oncology solutions increasing, industry projections suggest significant market expansion, as DelveInsight Business Research forecasts a 9.12% compound annual growth rate (CAGR ...